Focus Stocks
Candlesticks - Bearish Engulfing JNJ
Published on Thursday, 22 July 2010 03:09 Written by Christian Paolinetti
New York, July 22nd (TradersHuddle.com) - Shares of Johnson and Johnson (NYSE:JNJ) ended the trading session lower by $1.46 or -2.49% from its previous close. JNJ's price action formed what is considered to be a bearish engulfing candlestick chart pattern.
Johnson & Johnson (NYSE:JNJ) manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, Tylenol, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. The consumer healthcare products company was founded in 1886 and is based in New Brunswick, NJ.
JNJ's current stock range is defined by calculated support defined at $57.55 and by the resistance level at $61.73, which should be used by traders planning their trades.
Traders wanting to establish a position in JNJ stock need to pay close attention at the bearish engulfing pattern, since it could mark a trend reversal to current JNJ shares price action. The Bearish engulfing pattern is a leading warning sign, therefore traders should closely monitor price action for indications of a trend reversal. Below an Engulfing Bearish Candle Illustration:

Related Articles
- JNJ Close to Probable Support
- JNJ Had a Bearish Engulfing Candle
- JNJ Earnings Preview
- VisionCare Announces Close of Series E Expansion Financing and Board Changes
- Fish & Richardson Attorneys Tom Melsheimer, Tommy Jacks Help Whistleblower, State of Texas Earn Historic Settlement in Lawsuit Over Risperdal Medication
- JP Morgan - Worst Performing Dow Component
- Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results
- Biosense Webster Completes Enrollment in Ground-Breaking SMART-AF Trial
- Biosense Webster Announces FDA approval of the THERMOCOOL® SF Catheter in the United States
- Biosense Webster to offer a Comprehensive Electrophysiology (EP) Lab Solution
Related Partner Headlines
- First Global Downgrades Johnson & Johnson to Market Perform - Benzinga
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Cramer: 5 Earnings Trades the Market Always Gets Wrong - TheStreet.com
- Charges Eat Into Johnson & Johnson Profit - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Lower - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
/C O R R E C T I O N -- Daimler Corporate Communications/ -
RDA Microelectronics Announces Fourth Quarter and Full Year 2011 Financial Results -
Forum Subsea Technologies Wins Agreement With DOF Subsea for the Supply of Six Perry(TM) XLX ROV Systems -
StreamWIDE Enables Carriers to Run Value-Added Telephony Services on Amazon Web Services -
Forum Subsea Technologies Announces the Appointment of Two Senior Management Positions -
Citi California Pulse® Survey Finds Nearly Half of Californians Believe 2012 will be Better than 2011 -
Daimler Excels in Anniversary Year 2011: Group EBIT From Ongoing Business up by 24% to Record Level of Euro 9 Billion -
Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium










